Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development

Pathology Research and Practice

Volumn 210, Issue 12, 2014, Pages 909-915

  Zhu, Meng ^a   Zhang, Ning ^b   He, Shuixiang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Early diagnosis; Formalin fixed paraffin embedded; Gastric cancer; In situ hybridization; MicroRNA 106a

Indexed keywords

FORMALDEHYDE; MICRORNA; MICRORNA 106A; PARAFFIN; UNCLASSIFIED DRUG; MIRN106 MICRORNA, HUMAN;

ARTICLE; ATROPHIC GASTRITIS; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GASTRIC MUCOSA; HUMAN; IN SITU HYBRIDIZATION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOMA; UPREGULATION; ADENOCARCINOMA; FROZEN SECTION; GENE EXPRESSION PROFILING; GENETICS; LABORATORY DIAGNOSIS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; STOMACH MUCOSA; STOMACH TUMOR;

ADENOCARCINOMA; CARCINOGENESIS; FROZEN SECTIONS; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PARAFFIN EMBEDDING; SPECIMEN HANDLING; STOMACH NEOPLASMS; UP-REGULATION;

EID: 84949114505     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2014.07.008     Document Type: Article

References (34)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer. 2010, 127:2893-2917.
2. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
3. Imdahl A. Early diagnosis is crucial for prognosis in gastric cancer. MMW Fortschr. Med. 2008, 150:27.
4. Namikawa T., Kitagawa H., Iwabu J., Okabayashi T., Sugimoto T., Kobayashi M., Hanazaki K. Clinicopathological properties of the superficial spreading type early gastric cancer. J. Gastrointest. Surg. 2010, 14:52-57.
5. Hyung W.J., Cheong J.H., Kim J., Chen J., Choi S.H., Noh S.H. Analyses of prognostic factors and gastric cancer specific survival rate in early gastric cancer patients and its clinical implication. J. Korean Surg. Soc. 2003, 65:309-315.
6. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988, 48:3554-3560.
7. Srivastava A., Lauwers G. Gastric epithelial dysplasia: the Western perspective. Dig. Liver Dis. 2008, 40:641-649.
8. Leung W.K., Wu M.-s., Kakugawa Y., Kim J.J., Yeoh K.-g., Goh K.L., Wu K.-c., Wu D.-c., Sollano J., Kachintorn U. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008, 9:279-287.
9. Tsujiura M., Ichikawa D., Komatsu S., Shiozaki A., Takeshita H., Kosuga T., Konishi H., Morimura R., Deguchi K., Fujiwara H. Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer. 2010, 102:174-1179.
10. Chen P.-S., Su J.-L., Hung M-C. Dysregulation of MicroRNAs in cancer. J. Biomed. Sci. 2012, 19:90.
11. Melo S.A., Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett. 2011, 585:2087-2099.
12. Wheeler B.M., Heimberg A.M., Moy V.N., Sperling E.A., Holstein T.W., Heber S., Peterson K.J. The deep evolution of metazoan microRNAs. Evol. Dev. 2009, 11:50-68.
13. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A. MicroRNA expression profiles classify human cancers. Nature. 2005, 435:834-838.
14. Liu H., Zhu L., Liu B., Yang L., Meng X., Zhang W., Ma Y., Xiao H. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett. 2012, 316:196-203.
15. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer. 2006, 6:857-866.
16. Ambros V. The functions of animal microRNAs. Nature. 2004, 431:350-355.
17. Mayr C., Hemann M.T., Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science. 2007, 315:1576-1579.
18. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008, 133:217-222.
19. Habbe N., Koorstra J.B., Mendell J.T., Offerhaus G.J., Ryu J.K., Feldmann G., Mullendore M.E., Goggins M.G., Hong S.M., Maitra A. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol. Ther. 2009, 8:340-346.
20. Iorio M.V., Croce C.M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 2012, 4:143-159.
21. Zhang X., Chen J., Radcliffe T., LeBrun D.P., Tron V.A., Feilotter H. An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J. Mol. Diagn. 2008, 10:513-519.
22. Klopfleisch R., Weiss A., Gruber A. Excavation of a buried treasure - DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histol. Histopathol. 2011, 26:797.
23. Lewis F., Maughan N., Smith V., Hillan K., Quirke P. Unlocking the archive - gene expression in paraffin-embedded tissue. J. Pathol. 2001, 195:66-71.
24. Cronin M., Pho M., Dutta D., Stephans J.C., Shak S., Kiefer M.C., Esteban J.M., Baker J.B. Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. Am. J. Pathol. 2004, 164:35-42.
25. Li J., Smyth P., Flavin R., Cahill S., Denning K., Aherne S., Guenther S., O'Leary J., Sheils O. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol. 2007, 7:36.
26. Tang F., Hajkova P., O'Carroll D., Lee C., Tarakhovsky A., Lao K., Surani M.A. MicroRNAs are tightly associated with RNA-induced gene silencing complexes in vivo. Biochem. Biophys. Res. Commun. 2008, 372:24-29.
27. Kalmar A., Wichmann B., Galamb O., Spisák S., Tóth K., Leiszter K., Tulassay Z., Molnár B. Gene expression analysis of normal and colorectal cancer tissue samples from fresh frozen and matched formalin-fixed, paraffin-embedded (FFPE) specimens after manual and automated RNA isolation. Methods. 2013, 59:S16-S19.
28. Li B.-s., Zhao Y.-l., Guo G., Li W., Zhu E.-d., Luo X., Mao X.-h., Zou Q.-m., Yu P.-w., Zuo Q.-f. Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLOS ONE. 2012, 7:e41629.
29. Allegra A., Alonci A., Campo S., Penna G., Petrungaro A., Gerace D., Musolino C. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int. J. Oncol. 2012, 41:1897-1912.
30. Xiao B., Guo J., Miao Y., Jiang Z., Huan R., Zhang Y., Li D., Zhong J. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin. Chim. Acta. 2009, 400:97-102.
31. Zhang Y., Lu Q., Cai X. MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3. FEBS Lett. 2013, 587:3069-3075.
32. Wang Z., Liu M., Zhu H., Zhang W., He S., Hu C., Quan L., Bai J., Xu N. miR-106a is frequently upregulated in gastric cancer and inhibits the extrinsic apoptotic pathway by targeting FAS. Mol. Carcinog. 2013, 52:634-646.
33. Ryu J.K., Hong S.-M., Karikari C.A., Hruban R.H., Goggins M.G., Maitra A. Aberrant microRNA-155 expression is an early event in the multistep progression of pancreatic adenocarcinoma. Pancreatology. 2010, 10:66-73.
34. Yamamichi N., Shimomura R., Inada K.-i., Sakurai K., Haraguchi T., Ozaki Y., Fujita S., Mizutani T., Furukawa C., Fujishiro M. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development. Clin. Cancer Res. 2009, 15:4009-4016.